中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

1614 records (took 0.05 seconds)

    Augmented Reality Coordination Of Human-Robot Interaction
    12.
    发明申请
    Augmented Reality Coordination Of Human-Robot Interaction 有权

    公开(公告)号：US20240424673A1

    公开(公告)日：2024-12-26

    申请号：US18668453

    申请日：2024-05-20

    Applicant: The Regents of the University of Colorado, a body corporate

    Inventor： Daniel Szafir ,  Michael E. Walker ,  Hooman Hedayati

    IPC: B25J9/16 ,  B25J13/06 ,  G06F3/14 ,  G06T11/00 ,  G06V20/10

    Abstract: Systems and methods for human-robot communication. More particularly, some embodiments use augmented reality to facilitate communication of robot intention and teleoperation in human-robot cooperative environments. Various embodiments of the present technology provide a middleware that integrates augmented reality (AR) with novel teleoperation interfaces to increase operation effectiveness, support the user in conducting concurrent work, and decrease stress. Various embodiments provide predictive graphical interfaces such that a teleoperator controls a virtual robot surrogate, rather than directly operating the robot itself, providing the user with foresight regarding where the physical robot will end up and how it will get there. In accordance with various embodiments a user may select between two AR interfaces using such a surrogate: one focused on real-time control and one inspired by waypoint delegation.

    Filtering method for carrier phase measurements from open-loop tracking
    13.
    发明授权
    Filtering method for carrier phase measurements from open-loop tracking 有权

    公开(公告)号：US12166623B2

    公开(公告)日：2024-12-10

    申请号：US18249580

    申请日：2021-10-18

    Applicant: The Regents of the University of Colorado, a body corporate

    Inventor： Yang Wang ,  Yu T. Morton

    IPC: H04L27/38 ,  H04L27/00

    Abstract: DLOS and reflected signal components of an RF carrier signal are received. The reflected component is reflected from a point on the surface of the earth. The DLOS and reflected components are converted to digital DLOS IF and reflected IF signals, respectively. Modeled parameters are generated using the digital DLOS IF signal and locations of one or more antennas, the transmitter, and the point. A reference signal is generated based on the modeled parameters. The reference signal is correlated with the digital reflected IF signal to produce in-phase and quadrature-phase correlation results. A C/N0 and an estimated phase (EP) are calculated for the digital reflected IF signal from the correlation results. A KF is applied to the EP to produce an estimated filter phase (EFP). The KF is adapted to filter the EP using the estimated C/N0 to reduce cycle slips and noise in the EFP.

    INTACT PILL DELIVERY SYSTEM
    14.
    发明申请
    INTACT PILL DELIVERY SYSTEM 有权

    公开(公告)号：US20240382385A1

    公开(公告)日：2024-11-21

    申请号：US18765795

    申请日：2024-07-08

    Applicant: The Regents of the University of Colorado, a body corporate

    Inventor： Adam Green ,  Steven Lammers ,  Jennifer Wagner ,  Ken Liechty ,  Jahmel Jordon

    IPC: A61J15/00

    Abstract: A feeding tube configured to allow intact pills to pass through an internal lumen of the feeding tube. Some embodiments of the feeding tube include a main body having a lumen extending between a proximal end and a distal end of the main body. The proximal end includes an inlet aperture leading to the lumen and the distal end includes an outlet aperture fluidically coupled to the lumen. The main body includes a thin-walled transcutaneous section configured to temporarily receive a tubular structural support member that can operate as a traditional feeding tube. The tubular structural support member can be removed to allow a pill delivery device to deliver an intact pill through the lumen and out of the outlet aperture.

    Treatment of vascular and lymphatic disease
    20.
    发明授权
    Treatment of vascular and lymphatic disease 有权

    公开(公告)号：US12029732B2

    公开(公告)日：2024-07-09

    申请号：US17604858

    申请日：2020-04-20

    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE

    Inventor： Tamara Terzian ,  Neil Box

    IPC: A61K31/428 ,  A61K31/429 ,  A61P7/10

    CPC classification number: A61K31/428 ,  A61K31/429 ,  A61P7/10

    Abstract: Disclosed herein are compositions, methods, and systems useful in the prevention, management, or treatment of various conditions associated the lymphatic vasculature, including, but not limited to lymphedema. The disclosed methods and compositions are useful in reducing the activity of p53 in a subject at risk for or suffering from a disease or condition associated with lymphatic vasculature, including adults, children, infants, and embryos. Reduction in p53 activity may be achieve through reduction in one or more of p53 gene expression, p53 transcriptional activity, p53 DNA-binding affinity, etc. In many embodiments, the disease or condition is lymphedema, for example lymphedema associated with Milroy's disease, Klippel-Trenaunay and Cloves Syndromes. In many embodiments, treatment may involve administering a compound or pharmaceutically acceptable salt thereof to a subject in need thereof, exemplary compounds include, anti-p53 compounds, PFT, and PFT-β.

Patent Agency Ranking